• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by TELA Bio, Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 24, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
October 23, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 22, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce Third Quarter 2024 Financial Results
October 17, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
August 12, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
July 25, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce Second Quarter 2024 Financial Results
July 22, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
June 04, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
May 20, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports First Quarter 2024 Financial Results
May 09, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce First Quarter 2024 Financial Results
April 25, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
April 15, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
April 08, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
March 21, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
March 20, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
February 29, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Take Part in Connecting the Dots
December 05, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
November 16, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 10, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports Third Quarter 2023 Financial Results
November 09, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce Third Quarter 2023 Financial Results
October 26, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
September 18, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
August 16, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports Second Quarter 2023 Financial Results
August 09, 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap